Cargando…
Radioresistant Nasopharyngeal Carcinoma Cells Exhibited Decreased Cisplatin Sensitivity by Inducing SLC1A6 Expression
Cisplatin-based regimens are commonly used for the treatment of nasopharyngeal carcinoma (NPC) in patients who receive concurrent chemoradiotherapy. The sensitivity of NPC cells to cisplatin is closely associated with the efficacy of radiation therapy. In this study, we established two radioresistan...
Autores principales: | Hao, Wenwen, Wu, Lisha, Cao, Linhui, Yu, Jinxiu, Ning, Li, Wang, Jingshu, Lin, Xiaoping, Chen, Yanfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077170/ https://www.ncbi.nlm.nih.gov/pubmed/33927617 http://dx.doi.org/10.3389/fphar.2021.629264 |
Ejemplares similares
-
Twist1 promotes radioresistance in nasopharyngeal carcinoma
por: Zhang, Linli, et al.
Publicado: (2016) -
Simvastatin Sensitizes Radioresistant Prostate Cancer Cells by Compromising DNA Double-Strand Break Repair
por: Chen, Yu-An, et al.
Publicado: (2018) -
Identification of solamargine as a cisplatin sensitizer through phenotypical screening in cisplatin-resistant NSCLC organoids
por: Han, Yi, et al.
Publicado: (2022) -
Mangiferin Ameliorates Cisplatin Induced Acute Kidney Injury by Upregulating Nrf-2 via the Activation of PI3K and Exhibits Synergistic Anticancer Activity With Cisplatin
por: Sadhukhan, Pritam, et al.
Publicado: (2018) -
Multiple Mechanisms Involving in Radioresistance of Nasopharyngeal Carcinoma
por: Zhan, Yuting, et al.
Publicado: (2020)